Palomino Laboratories (PALX) Accounts Payables (2022 - 2025)
Palomino Laboratories (PALX) reported Accounts Payables of $55687.0 for Q4 2025, up 1592.1% on a YoY basis from $3291.0 in Q4 2024, and down 8.64% sequentially from $60952.0 in Q3 2025.
Palomino Laboratories (PALX) Accounts Payables (2022 - 2025) Analysis & Trends
Palomino Laboratories (PALX) has 4 years of Accounts Payables data on file, last reported at $55687.0 in Q4 2025.
- For the quarter ending Q4 2025, Accounts Payables rose 1592.1% year-over-year to $55687.0; the trailing twelve-month figure through Dec 2025 stood at $55687.0 (up 1592.1% YoY), and the FY2025 full-year result was $55687.0, up 1592.1% from the prior year.
- Accounts Payables declined to $55687.0 in Q4 2025, from $60952.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $60952.0 in Q3 2025 to a low of $58.0 in Q4 2023.
- A 4-year average of $35037.1 and a median of $43954.0 in 2024 frame the typical range for Accounts Payables.
- Across the five-year window, Accounts Payables slumped 99.54% in 2023 and jumped 5574.14% in 2024, its largest moves.
- Tracing PALX's Accounts Payables over 4 years: stood at $12500.0 in 2022, then tumbled by 99.54% to $58.0 in 2023, then jumped by 5574.14% to $3291.0 in 2024, then jumped by 1592.1% to $55687.0 in 2025.
- Business Quant data shows PALX's Accounts Payables at $55687.0 in Q4 2025, $60952.0 in Q3 2025, and $40781.0 in Q2 2025.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55,687.00 |
| Sep 30, 2025 | 60,952.00 |
| Jun 30, 2025 | 40,781.00 |
| Mar 31, 2025 | 45,816.00 |
| Dec 31, 2024 | 3,291.00 |
| Sep 30, 2024 | 46,757.00 |
| Jun 30, 2024 | 43,954.00 |
| Mar 31, 2024 | 47,112.00 |
| Dec 31, 2023 | 58.00 |
| Sep 30, 2023 | 28,500.00 |
| Dec 31, 2022 | 12,500.00 |